Possible application of natural killer cells and interleukin-2 in therapy of human leukemia
Lotzová, E.
Progress in Clinical and Biological Research 244: 259-266
1987
ISSN/ISBN: 0361-7742 PMID: 3498951 Document Number: 303002
Document emailed within 1 workday
Related Documents
Shirakawa, F.; Tanaka, Y.; Eto, S.; Suzuki, H.; Yodoi, J.; Yamashita, U. 1986: Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells) Journal of Immunology 137(2): 551-556Kimmig, A.; Gekeler, V.; Neumann, M.; Frese, G.; Handgretinger, R.; Kardos, G.; Diddens, H.; Niethammer, D. 1990: Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells Cancer Research 50(21): 6793-6799
Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Kaufmann, Y.; Levanon, M.; Davidsohn, J.; Ramot, B. 1987: Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity Journal of Immunology 139(3): 977-982
Weil-Hillman, G.; Voss, S.D.; Fisch, P.; Schell, K.; Hank, J.A.; Sosman, J.A.; Sugamura, K.; Sondel, P.M. 1990: Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype Cancer Research 50(9): 2683-2691
Hayakawa, K.; Salmeron, M.A.; Kornbluth, J.; Bucana, C.; Itoh, K. 1991: The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone Journal of Immunology 146(7): 2453-2460
Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M. 1991: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells Journal of Immunology 146(9): 3074-3081
Itoh, K.; Tilden, A.B.; Balch, C.M. 1985: Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells Cancer Research 45(7): 3173-3178
Agah, R.; Malloy, B.; Sherrod, A.; Mazumder, A. 1988: Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice Cancer Research 48(8): 2245-2248
Goodman, D.J.; Von Albertini, M.; Willson, A.; Millan, M.T.; Bach, F.H. 1996: Direct activation of porcine endothelial cells by human natural killer cells Transplantation 61(5): 763-771
Merluzzi, V.J.; Trail, P.A.; Last-Barney, K. 1986: Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow Journal of Immunology 137(8): 2425-2427
Azuma, M.; Cayabyab, M.; Buck, D.; Phillips, J.H.; Lanier, L.L. 1992: Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line Journal of Immunology 149(4): 1115-1123
Renoux, G. 1984: Effects of diethyldithiocarbamate on human natural killer cells Journal of Immunology 133(4): 2278
Sahraoui, Y.; Allouche, M.; Perrakis, M.; Clemenceau, C.; Jasmin, C.; Georgoulias, V. 1992: Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells Leukemia 6(4): 295-303
Lin, W.; Yan-Chen, L.; Jian, L.; Jin-Kun Chen 2011: Reduced Expression of Chemerin is Associated With a Poor Prognosis and a Lowed Infiltration of Both Dendritic Cells and Natural Killer Cells in Human Hepatocellular Carcinoma Clinical Laboratory 57(11-12): 879-885
Griffin, J.D.; Hercend, T.; Beveridge, R.; Schlossman, S.F. 1983: Characterization of an antigen expressed by human natural killer cells Journal of Immunology 130(6): 2947-2951
Tanaka, M.; Sato, S.; Miyatake, T. 1985: Subsets of human natural killer cells in neurological disorders Rinsho Shinkeigaku 25(3): 314-319
Rabinowich, H.; Pricop, L.; Herberman, R.B.; Whiteside, T.L. 1994: Expression and function of CD7 molecule on human natural killer cells Journal of Immunology 152(2): 517-526
Kemp, K.; Hviid, L.; Kharazmi, A.; Kemp, M. 1997: Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major Scandinavian Journal of Immunology 46(5): 495-499
Methenitou, G.; Maravelias, C.; Athanaselis, S.; Dona, A.; Koutselinis, A. 2001: Immunomodulative effects of aflatoxins and selenium on human natural killer cells Veterinary and Human Toxicology 43(4): 232-234